Executive Vice President, Chief Medical Officer @ FibroGen, Inc.
Senior Vice President, Global Head of Immunology, Infectious Disease, and Ophthalmology Development @ Genentech
Vice President and Global Head of Respiratory, Actemra, ID, and Metabolism Product Development @ Genentech
Senior Group Medical Director, Global Head of Actemra and Infectious Disease Product Development @ Genentech
Senior Group Medical Director, Global Head of Actemra Development Program @ Genentech
Group Medical Director, Global Head of Actemra Development Program @ Genentech
Associate Group Medical Director, Product Development Immunology and Respiratory @ Genentech
Member, Board Of Directors @ Genentech Foundation
Mark Eisner's Education
Stanford University
AB (Human Biology)
1984 - 1988
University of Pennsylvania School of Medicine
MD
1988 - 1992
University of California, Berkeley, School of Public Health
MPH (Epidemiology and Biostatistics)
1999 - 2000
Mark Eisner's Skills
Drug development
Clinical trials
Management
Clinical Research
Clinical Development
Immunology
Internal Medicine
Medicine
Epidemiology
Translational Medicine
Mark Eisner's Summary
Mark Eisner, based in California, United States, is currently a Chief Medical Officer at Sonoma Biotherapeutics, bringing experience from previous roles at Aer Therapeutics, Inc., FibroGen, Inc. and Genentech. Mark Eisner holds a 1984 - 1988 AB in Human Biology @ Stanford University. With a robust skill set that includes Drug development, Clinical trials, Management, Clinical Research, Clinical Development and more, Mark Eisner contributes valuable insights to the industry. Mark Eisner has 2 emails on RocketReach.